日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Differential prognostic roles and clinical implications of mitochondrial and genomic tRNA-derived fragments in colorectal liver metastases

线粒体和基因组tRNA衍生片段在结直肠癌肝转移中的不同预后作用和临床意义

Zirnbauer, Rebecca; Ammon, Daphni; Renner, Annalena; Hartman, Noam; Kalinina, Polina; Starlinger, Patrick; Stremitzer, Stefan; Schwarz, Christoph; Kaczirek, Klaus; Bergmann, Michael; Pils, Dietmar; Laengle, Johannes

Total Metastases Volume and Relative Volume Reduction After Neoadjuvant Therapy Predict Outcome After Liver Resection of Colorectal Liver Metastases

新辅助治疗后总转移灶体积和相对体积缩小情况可预测结直肠癌肝转移瘤肝切除术后的预后

Lindenlaub, Florian; Asenbaum, Ulrika; Schwarz, Christoph; Makolli, Jessica; Mittlböck, Martina; Stremitzer, Stefan; Kaczirek, Klaus

Evaluation of Eosinophilic Cationic Protein as a Marker of Alveolar and Cystic Echinococcosis

嗜酸性阳离子蛋白作为泡型和囊型包虫病标志物的评价

Julian Frederic Hotz, Klaus Kaczirek, Stefan Stremitzer, Fredrik Waneck, Herbert Auer, Thomas Perkmann, Manuel Kussmann, Philipp Karl Bauer, Rui-Yang Chen, Richard Kriz, Heinz Burgmann, Michael Ramharter, Heimo Lagler

When Does Physician Use of AI Increase Liability?

医生使用人工智能何时会增加法律责任?

Tobia, Kevin; Nielsen, Aileen; Stremitzer, Alexander

DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells

DNA 损伤预测结直肠肝转移的预后和治疗反应优于免疫原性细胞死亡和 T 细胞

Johannes Laengle, Judith Stift, Agnes Bilecz, Brigitte Wolf, Andrea Beer, Balazs Hegedus, Stefan Stremitzer, Patrick Starlinger, Dietmar Tamandl, Dietmar Pils, Michael Bergmann

Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer

雌激素受体β基因变异与局部晚期胃癌患者的总生存期

Sunakawa, Y; Cao, S; Berger, M D; Matsusaka, S; Yang, D; Zhang, W; Ning, Y; Parekh, A; Stremitzer, S; Mendez, A; Okazaki, S; Wakatsuki, T; Azuma, M; Shimada, K; Watanabe, M; Koizumi, W; Wu, A H; Lenz, H-J

Genetic variations in immunomodulatory pathways to predict survival in patients with locoregional gastric cancer

免疫调节通路基因变异预测局部区域性胃癌患者的生存率

Sunakawa, Y; Cao, S; Volz, N B; Berger, M D; Yang, D; Parekh, A; Zhang, W; Matsusaka, S; Ning, Y; Stremitzer, S; Stintzing, S; Sebio, A; Okazaki, S; Wakatsuki, T; Azuma, M; Watanabe, M; Koizumi, W; Wu, A H; Lenz, H-J

CXCR4 polymorphism predicts progression-free survival in metastatic colorectal cancer patients treated with first-line bevacizumab-based chemotherapy

CXCR4多态性可预测接受一线贝伐单抗化疗的转移性结直肠癌患者的无进展生存期

Matsusaka, S; Cao, S; Hanna, D L; Sunakawa, Y; Ueno, M; Mizunuma, N; Zhang, W; Yang, D; Ning, Y; Stintzing, S; Sebio, A; Stremitzer, S; Yamauchi, S; Parekh, A; Okazaki, S; Berger, M D; El-Khoueiry, R; Mendez, A; Ichikawa, W; Loupakis, F; Lenz, H-J

Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus Bevacizumab

TLR1 I602S 多态性对接受 FOLFIRI 联合贝伐单抗治疗的转移性结直肠癌患者的临床意义

Okazaki, Satoshi; Loupakis, Fotios; Stintzing, Sebastian; Cao, Shu; Zhang, Wu; Yang, Dongyun; Ning, Yan; Sunakawa, Yu; Stremitzer, Stefan; Matsusaka, Satoshi; Berger, Martin D; Parekh, Anish; West, Jordan D; Miyamoto, Yuji; Suenaga, Mitsukuni; Schirripa, Marta; Cremolini, Chiara; Falcone, Alfredo; Heinemann, Volker; DePaolo, R William; Lenz, Heinz-Josef

Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection

参与血管形态发生和成熟的基因表达可预测贝伐单抗化疗在接受肝切除术患者中的疗效

Stremitzer, Stefan; Zhang, Wu; Yang, Dongyun; Ning, Yan; Sunakawa, Yu; Matsusaka, Satoshi; Parekh, Anish; Okazaki, Satoshi; Hanna, Diana; Astrow, Stephanie H; Moran, Miriana; Hernandez, Jose; Stephens, Craig; Scherer, Stefan J; Stift, Judith; Wrba, Friedrich; Gruenberger, Thomas; Lenz, Heinz-Josef